Probable early-onset alzheimer's disease in an apolipoprotein E2 homozygote

3Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To describe a case of early-onset Alzheimer's disease (AD) in an apolipoprotein (Apo) ε2/ε2 homozygote. Background: Apo ε2/ε2 is the rarest of the ApoE genotypes, representing only 1.4% of the population. Cognitive decline in ApoE ε2 homozygotes has rarely been reported. Case Report/Methods: We report a 58-year-old Apo ε2/ε2 female who meets clinical criteria for probable AD as confirmed by neuropsychological testing, positron emission/computed tomography scan, CSF analysis and genetic screening for known mutations. Results: The clinical course is typical of AD, with progressive cognitive and functional decline. Conclusion: Clinically confirmed early-onset AD is atypical in ApoE2 homozygotes but can occur. © 2010 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Cole, L., Belden, C., Jacobson, S., Liebsack, C., Myers, K., Reninger, C., … Sabbagh, M. N. (2010). Probable early-onset alzheimer’s disease in an apolipoprotein E2 homozygote. Dementia and Geriatric Cognitive Disorders, 30(5), 387–391. https://doi.org/10.1159/000320589

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free